Pediatric Allergen Trial

1,100 pediatric patients recruited for Ready. Set. Food!

How 1nHealth’s targeted digital strategies and expertise led to the successful early enrollment of 1,100 diverse participants for the Early Allergen System Experience (EASE) trial.

30%

diverse representation achieved in total enrollment.

Diverse Representation

2

months saved from original LPI projections.

Accelerated Enrollment

“1nHealth’s expertise in digital recruitment played a pivotal role in connecting eligible participants through targeted campaigns, ensuring the process was efficient and reflective of real-world conditions.”

— Daniel Zakowski, CEO of Ready. Set. Food!

Our results

1,100

pediatric patients enrolled in the EASE trial

30%

diverse representation achieved

60%

of disqualifications converted to referrals after re-engagement

The challenge

Trust Was Key: Pediatric allergen trials face unique hurdles, from engaging parents of young participants to addressing the emotional weight of managing childhood allergies. These trials require a deep understanding of not just the medical condition but also the psychological and logistical barriers families face.

Large Scale Recruitment: Ready. Set. Food! had spent years thoughtfully designing this trial, but needed a decentralized approach to reach their enrollment goal of 1,100 participants. The EASE trial explores how early and consistent allergen introduction can address longstanding challenges parents face, such as sustaining allergen feeding and managing associated costs. Recruitment also needed total enrollment to be both ethnically and geographically diverse to provide true-to-life representation of the real world consumer base Ready. Set. Food! serves.

The strategy

A Message That Resonates: Messaging was one of the first things we wanted to get aligned with. We knew finding participants wasn’t the challenge—finding the right participants was. Our digital specialists prioritized creating visuals and messaging that would immediately connect with target audiences, assuring parents they weren’t alone and that treatment was available. Our core messaging was split into three main themes:

Parents and guardians concerned about infant’s immediate health:

This angle appealed to parents aiming to mitigate any potential health concerns or allergy development for their child.

Improving your child’s quality of life:

This angle leads with quality-of-life improvements that can come if an allergy development is prevented.

Pioneering research and helping others:

This angle motivates individuals to make a difference for others like them while contributing to scientific advancements.

The solution

Analyzing Disqualification Data: Despite a high submission rate (24.4%) one of the challenges we encountered was an unusually high number of disqualified referrals.

Optimizing Patient Re-Engagement: We identified a frequent disqualification was due to age (8-10 weeks) so we scheduled re-invites once submissions were of qualifying age (11-19 weeks). In total, we converted 60% of those disqualifications into qualified referrals.

The results

End-to-End Enrollment: By owning every step of the enrollment process, 1nHealth was able to help deliver successful recruitment two months ahead of schedule. We’re proud to contribute towards the advancement of research on early allergens to improve infant health outcomes and reduce healthcare costs around the world, all while maintaining the highest standards of integrity and data quality throughout every trial.

Accelerate enrollment at any scale

"1nHealth’s expertise in digital recruitment played a pivotal role in connecting eligible participants through targeted campaigns, ensuring the process was efficient and reflective of real-world conditions."

— Sponsor